Our Latest Stories
![](/optim/dotcom/content-app/articles/our-science/driving-excellence-biopharma-formula-success-mclaren-racing/hero-driving-excellence-biopharma-formula-success-mclaren-racing_20250206092215.jpg?size=medium)
Our Science
February 12, 2025
Driving Excellence in Biopharma: Our Formula for Success with McLaren Racing
![](https://img.youtube.com/vi/KUkgTnzhq7w/0.jpg)
United by Purpose
Each of us plays a unique role in bringing our purpose to life.
About Us
![](/optim/dotcom/pages/images/our-company/our-strategy/herobanner-strategy-4_20230515142620.jpg?size=medium)
Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
83
Compounds in clinical development
26
Clinical trials in phase 3
![](/optim/dotcom/pages/images/career/career-portal-thumbnail_20240515151016.jpg?size=large)
Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.
Our Latest Press Releases
February 19, 2025
Press Release: Sanofi and CD&R sign Opella share purchase agreement
February 18, 2025
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
February 13, 2025
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
February 13, 2025
Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study